Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

Share Price is delayed by 15 minutes
Get Live Data
498.00    -16.00 (-3.11%)
Bid:
498.00
Ask:
506.00
Spread: 8.00 (1.606%)
Market Cap: £251.41m
FSJ Live PriceLast checked at - London Stock Exchange

Intraday James Fisher and Sons Share Chart

Half year trading update

17 Jul 2023 07:00

RNS Number : 1487G
Fisher (James) & Sons plc
17 July 2023
 

17 July 2023

James Fisher and Sons plc

Half year trading update

 

James Fisher and Sons plc (FSJ.L) ("James Fisher" or the "Group"), today provides an update on trading for the six months ended 30 June 2023 ("the period"), ahead of the publication of its Half Year results on 21 September 2023.

 

Trading summary

The Board is pleased to report that the encouraging start to the year was maintained through the second quarter. Group revenue from continuing operations in the period is expected to be c.£250m, representing growth of c.16% compared to the same period in 2022. Underlying operating profit and operating profit margin from continuing operations are both expected to show modest growth compared to the same period in 2022, with the revenue uplift more than offsetting increased investment to strengthen core capabilities within the Group, including the formation of our Business Excellence team. 

 

All three divisions delivered revenue and profit growth compared to the same period in 2022, with the Energy division performing particularly well following strong market demand for well-testing, bubble curtain and artificial lift products and services. Defence is expected to report a modest profit for the period compared to a modest loss in 2022. Within the Maritime Transport division, Tankships has maintained its good performance, with high tanker utilisation and solid day rates for spot charters. Fendercare's ship-to-ship transfer business has stabilised at levels in line with H2 2022.

 

Financial position

Net bank borrowings at 30 June 2023 were c.£147m, compared to £133m at 31 December 2022. The normal seasonality of the business, unwind of working capital balances and costs associated with the £210m new revolving credit facility have led to a cash outflow in the first half of the year despite asset sales generating net proceeds of c.£20m in the period. The Group continues to expect net bank borrowings to reduce by the end of the 2023 financial year, in line with its usual trading profile.

 

Outlook

The Group enters the second half of the year mindful of heightened macro-economic uncertainty, however the Group's markets remain resilient and the Board's expectations for the full year remain unchanged.

 

Jean Vernet, Chief Executive Officer, commented:

"I am pleased with the Group's first half performance, with all three divisions contributing to revenue growth of 16%, alongside a modest improvement in margins. We are starting to see the benefits of the operational improvements being implemented throughout James Fisher. These, combined with the previously announced business and asset disposals and the refinancing concluded in June, provide us with a stronger platform for the future. Despite uncertainty in the macro-economic environment, the Group's markets remain resilient and the Board's outlook for the full year remains unchanged."

 

For further information:

James Fisher and Sons plc

Jean Vernet

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

020 7614 9503

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUQWMUPWPUQ
Date   Source Headline
22nd May 202612:22 pmRNS-RNotice of Defence Division Investor Event
18th May 20269:30 amRNSDirector/PDMR Shareholding
13th May 20261:48 pmRNSResult of AGM
22nd Apr 202611:15 amRNSDirector/PDMR Shareholding
8th Apr 20269:28 amRNSAnnual Report and Accounts and Notice of AGM
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
16th Feb 20267:00 amRNSNotice of Analyst and Investor Presentations
13th Feb 20263:10 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
27th Jan 20262:05 pmRNSHolding(s) in Company
15th Jan 20262:00 pmRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20254:08 pmRNSHolding(s) in Company
26th Sep 20258:35 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSHalf Year Results
21st Aug 20257:00 amRNSNotice of Analyst and Investor Presentations
1st Aug 20258:00 amRNSTotal Voting Rights and Share Capital
29th Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
16th Jul 20257:00 amRNSTotal Voting Rights and Share Capital
16th Jun 20254:35 pmRNSBlock listing six monthly return
23rd May 202511:46 amRNSBlock Listing Application
13th May 20252:36 pmRNSResults of Annual General Meeting
6th May 202510:39 amRNSNotification of Directors' Interest in Shares
28th Apr 20252:33 pmRNSNotification of Directors' Interest in Shares
4th Apr 20259:30 amRNSAnnual Report and Accounts 2024 and Notice of AGM
20th Mar 20257:00 amRNSFull Year Results
14th Mar 20259:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20257:56 amRNSHolding(s) in Company
16th Jan 20259:58 amRNSHolding(s) in Company
16th Dec 202410:59 amRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Sep 20243:35 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSSigning of £95m of committed bank facilities
10th Sep 20247:00 amRNSHalf year results
6th Sep 20242:10 pmRNSCompletion of Disposal of Martek Holdings Limited
8th Jul 20244:19 pmRNSHolding(s) in Company
8th Jul 202410:04 amRNSCompletion of RMSpumptools Disposal
28th Jun 20249:26 amRNSDirector Declaration
17th Jun 202411:32 amRNSBlock listing six monthly return
13th Jun 20246:15 pmRNSResults of the General Meeting
12th Jun 20241:43 pmRNSNotification of Directors' Interests in Shares
30th May 20244:48 pmRNSResults of Annual General Meeting
30th May 20243:34 pmRNSDirector Declaration
24th May 20243:18 pmRNSPublication of Circular and Notice of GM
29th Apr 20245:39 pmRNSAnnual Report and Accounts 2023 and Notice of AGM
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.